HCA Healthcare (HCA) PT Set at $97.00 by Argus

HCA Healthcare (NYSE:HCA) has been assigned a $97.00 price objective by analysts at Argus in a research note issued on Wednesday, January 10th. The firm currently has a “buy” rating on the stock. Argus’ price target points to a potential downside of 5.13% from the company’s current price.

HCA has been the subject of several other research reports. Credit Suisse Group reissued an “outperform” rating and issued a $25.00 price target on shares of HCA Healthcare in a report on Tuesday, December 26th. Robert W. Baird reissued a “buy” rating on shares of HCA Healthcare in a report on Thursday, September 28th. Raymond James Financial lowered shares of HCA Healthcare from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, October 18th. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target for the company. in a report on Wednesday, December 20th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $95.00 price target on shares of HCA Healthcare in a report on Friday, October 13th. Four equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seventeen have issued a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Hold” and a consensus target price of $102.85.

HCA Healthcare (NYSE:HCA) traded up $1.08 during trading hours on Wednesday, hitting $102.24. 3,192,172 shares of the stock traded hands, compared to its average volume of 2,553,019. The company has a debt-to-equity ratio of -6.58, a quick ratio of 1.41 and a current ratio of 1.62. The stock has a market cap of $35,918.63, a price-to-earnings ratio of 17.21, a price-to-earnings-growth ratio of 1.14 and a beta of 0.55. HCA Healthcare has a 52-week low of $71.18 and a 52-week high of $106.84.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.25. The firm had revenue of $11.56 billion during the quarter, compared to analyst estimates of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $1.80 EPS. equities research analysts forecast that HCA Healthcare will post 8.6 EPS for the current year.

In other news, SVP Victor L. Campbell sold 8,000 shares of the business’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total transaction of $624,000.00. Following the transaction, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total transaction of $167,700.00. Following the transaction, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 78,725 shares of company stock worth $7,132,797. 2.90% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the company. Argent Capital Management LLC boosted its position in shares of HCA Healthcare by 1.2% during the 2nd quarter. Argent Capital Management LLC now owns 4,370 shares of the company’s stock valued at $381,000 after acquiring an additional 50 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of HCA Healthcare by 14.0% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after acquiring an additional 143 shares during the last quarter. Thrivent Financial For Lutherans boosted its position in shares of HCA Healthcare by 1.5% during the 2nd quarter. Thrivent Financial For Lutherans now owns 10,810 shares of the company’s stock valued at $943,000 after acquiring an additional 160 shares during the last quarter. Acrospire Investment Management LLC boosted its position in shares of HCA Healthcare by 14.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the last quarter. Finally, Dai Ichi Life Insurance Company Ltd boosted its position in shares of HCA Healthcare by 1.2% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 20,577 shares of the company’s stock valued at $1,794,000 after acquiring an additional 236 shares during the last quarter. 75.23% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This report was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/01/hca-healthcare-hca-pt-raised-to-97-00.html.

About HCA Healthcare

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply